RMgmDB - Rodent Malaria genetically modified Parasites

Summary

RMgm-1103
Malaria parasiteP. berghei
Genotype
MutatedGene model (rodent): PBANKA_1349800; Gene model (P.falciparum): PF3D7_1335900; Gene product: thrombospondin-related anonymous protein | sporozoite surface protein 2 (sporozoite surface protein 2; SSP2; SSP-2; TRAP)
Details mutation: The endogenous P. berghei trap gene replaced with the ortholog of P. vivax
Phenotype Sporozoite; Liver stage;
Last modified: 9 August 2014, 22:03
  *RMgm-1103
Successful modificationThe parasite was generated by the genetic modification
The mutant contains the following genetic modification(s) Gene mutation
Reference (PubMed-PMID number) Reference 1 (PMID number) : 24379295
MR4 number
Parent parasite used to introduce the genetic modification
Rodent Malaria ParasiteP. berghei
Parent strain/lineP. berghei ANKA
Name parent line/clone Not applicable
Other information parent line
The mutant parasite was generated by
Name PI/ResearcherBauza, K; Reyes-Sandoval. A
Name Group/DepartmentThe Jenner Institute
Name InstituteUniversity of Oxford
CityOxford
CountryUK
Name of the mutant parasite
RMgm numberRMgm-1103
Principal namePbANKA-PvTRAP(r)PbTRAP
Alternative name
Standardized name
Is the mutant parasite cloned after genetic modificationYes
Phenotype
Asexual blood stageNot different from wild type
Gametocyte/GameteNot different from wild type
Fertilization and ookineteNot different from wild type
OocystNot different from wild type
SporozoiteSlightly reduced (but not significant) numebers of salivary gland sporozoites
Liver stageSlightly reduced (but not significant) prepatent period after iv injection of 1.000 salivary gland sporozoites.
Additional remarks phenotype

Mutant/mutation
In the mutant the endogenous P. berghei trap gene is replaced by the trap gene of P. vivax (PVX_082735). P. vivax trap is under control of the P. berghei trap regulatory sequences.

Protein (function)
TRAP is a type 1 transmembrane protein, containing two adhesive domains in its extracellular portion, an A-domain of von Willebrand factor and a thrombospondin type I repeat (TSR, TSP). TRAP is located in the micronemes of sporozoites. The protein plays a role in the gliding motility of sporozoites and invasion of host cells as has been shown by analysis of mutant parasites lacking expression of TRAP

Phenotype
The phenotype analyses indicate that the TRAP protein of P. vivax can  complement the activity of the endogenous P. berghei TRAP protein.

Additional information
In the paper the development of new recombinant ChAd63 and MVA vectors expressing P. vivax TRAP (PvTRAP) is described that show ability to induce high antibody titers and T cell responses in mice. In addition,  a novel way of assessing the efficacy of new candidate vaccines against P. vivax is reported using a fully infectious transgenic P. berghei parasite expressing P. vivax TRAP to allow studies of vaccine efficacy and protective mechanisms in rodents. Using this model, it is found that both CD8+ T cells and antibodies mediated protection against malaria using virus-vectored vaccines.

Other mutants


  Mutated: Mutant parasite with a mutated gene
Details of the target gene
Gene Model of Rodent Parasite PBANKA_1349800
Gene Model P. falciparum ortholog PF3D7_1335900
Gene productthrombospondin-related anonymous protein | sporozoite surface protein 2
Gene product: Alternative namesporozoite surface protein 2; SSP2; SSP-2; TRAP
Details of the genetic modification
Short description of the mutationThe endogenous P. berghei trap gene replaced with the ortholog of P. vivax
Inducable system usedNo
Short description of the conditional mutagenesisNot available
Additional remarks inducable system
Type of plasmid/construct(Linear) plasmid double cross-over
PlasmoGEM (Sanger) construct/vector usedNo
Modified PlasmoGEM construct/vector usedNo
Plasmid/construct map
Plasmid/construct sequence
Restriction sites to linearize plasmid
Selectable marker used to select the mutant parasitehdhfr/yfcu
Promoter of the selectable markerpbdhfr
Selection (positive) procedurepyrimethamine
Selection (negative) procedureNo
Additional remarks genetic modificationA codon-optimized gene of P. vivax TRAP (UniProt A5K806, residues Asp25 to Lys493) was used.
A synthetic allele composed of the protein-coding sequence of P. vivax TRAP (accession number XM_001614097) from the Salvador I strain, which was codon optimized for expression in P. berghei using the GeneOptimizer software, which evaluates factors that can compromise mRNA stability, such as ribosomal binding sites, extreme GC content, cryptic splice and consensus sites, repeats, and secondary structures (Invitrogen, United Kingdom).
See the paper of details of generation of the construct using phage recombinase-mediated engineering of Plasmodium DNA in E. coli.
Additional remarks selection procedure
Primer information: Primers used for amplification of the target sequences  Click to view information
Primer information: Primers used for amplification of the target sequences  Click to hide information
Sequence Primer 1
Additional information primer 1
Sequence Primer 2
Additional information primer 2
Sequence Primer 3
Additional information primer 3
Sequence Primer 4
Additional information primer 4
Sequence Primer 5
Additional information primer 5
Sequence Primer 6
Additional information primer 6